CSI
AMGN icon

Cross Staff Investments’s Amgen AMGN Stock Holding History

Cross Staff Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$227K Hold
626
– – 0.13% 128
2026
Q1 		$220K Hold
626
– – 0.11% 120
2025
Q4 		$205K Buy
+626
New +$199K 0.11% 129
2024
Q4 		– Sell
-626
Closed -$202K – 123
2024
Q3 		$202K Buy
+626
New +$205K 0.16% 125

Other funds holding AMGN

Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return

Cross Staff Investments's AMGN Position: Q2 2026 in Review

Cross Staff Investments held its Amgen (AMGN) position steady in Q2 2026 at 626 shares worth $227K. The position accounts for 0.13% of the portfolio, ranked #128.

Cross Staff Investments first reported a position in AMGN in Q3 2024 and has held it in 4 quarters since. 1,372 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Cross Staff Investments held 626 shares of Amgen worth $227K as of Q2 2026.
  • Cross Staff Investments left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 0.13% of Cross Staff Investments's portfolio in Q2 2026, its #128 holding.
  • Cross Staff Investments first reported a position in Amgen in Q3 2024 and has held it in 4 quarters since.
  • 1,372 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Cross Staff Investments's 13F filing for Q2 2026, filed 22 Jul 2026.